Announcements Trials
Browse Landscape

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 24Observational 2

Sponsor

Cancer Type

Gastrointestinal 18Breast 18Thoracic 13Genitourinary 11Other hematologic neoplasm 7Dermatologic 7Tumor-Agnostic 5Gynecologic 5Sarcoma 3Plasma cell 3Other solid neoplasm 2CNS 2Lymphoid 1Head & Neck 1

Conditions

Solid Tumors 1Solid Tumor 1

Interventions

Blood Specimen Collection 8Surveys and Questionnaires 7Fluorodeoxyglucose F18 4larotrectinib 3Magnetic Resonance Imaging 3Data Collection 3envafolimab 2Watchful Waiting 2Specimen Handling 2Quality of Life 2Psychiatric Rehabilitation 2Microarray Analysis 2Immunoenzyme Techniques 2Histocompatibility Testing 2Genetic Testing 2Gene Expression Profiling 2Fluorouracil 2Drug Therapy 2Blood Component Removal 2trifluridine tipiracil drug combination 1tegafur-gimeracil-oteracil 1etoposide phosphate 1disitamab vedotin 1alovudine 1Wechsler Scales 1Vascular Endothelial Growth Factor A 1Tumor Burden 1Tomography, Optical Coherence 1Tomography, Emission-Computed 1Tissue Banks 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Specimen Handling × Other solid neoplasm × Clear all
NCT07137312 2025-12-23

Ex Vivo Expansion (ACT-X)

Mayo Clinic

Recruiting
24 enrolled
Other solid neoplasm

Solid Tumor

NCT01345513 2020-03-23

Feasibility Clinical Study of Targeted and Genome-Wide Sequencing

University Health Network, Toronto

Completed
50 enrolled 8 charts
Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡